Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: Cancer Causes Control. 2019 May 22;30(7):721–732. doi: 10.1007/s10552-019-01185-z

Fig. 2 — Surveillance, Epidemiology, and End Results Head and Neck Patterns of Care Specific Chemotherapies Received by Year of Diagnosis (weighted % among all who received any chemotherapy, unweighted n=1,222)

NOTE: Cetuximab not measured in 1997

Significant increasing Cochran-Armitage Test for Trend

Significant decreasing Cochran-Armitage Test for Trend

Inline graphic — Surveillance, Epidemiology, and End Results Head and Neck Patterns of Care Specific Chemotherapies Received by Year of Diagnosis (weighted % among all who received any chemotherapy, unweighted n=1,222)

NOTE: Cetuximab not measured in 1997

Significant increasing Cochran-Armitage Test for Trend

Significant decreasing Cochran-Armitage Test for Trend